Skip links

Dr. Peter So

Specialist in Clinical Oncology

Dr. Peter So
About Dr. Peter So
  • MBChB(CUHK)
  • FRCR
  • FHKCR
  • FHKAM (Radiology)
  • MBA (Healthcare) (CUHK)

Local Experience with High Grade Glioma (Abstract), 7th HKICC in 2000, PI

Stereotactic Radiotherapy plus External Radiotherapy as Radical Treatment in NPC with First Local Recurrence, QEH Experience (Abstract), 9th Annual Scientific Meeting of HKCR in 2001, PI

Treatment of Endometrial Stromal Sarcoma, QEH Experience (Abstract), 9th Annual Scientific Meeting of HKCR in 2001, PI

Planned Stereotactic Radiotherapy Boost for Early T-stage NPC, QEH Experience (Abstract), 8th HKICC in 2001, PI

Stereotactic Radiotherapy Boost for Persistent Local Disease after Primary External Radiotherapy, QEH Experience (Abstract), 8th HKICC in 2001, PI

ASPIRATION: Phase II Study of continued Erlotinib beyond RECIST progression in Asian patients with epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC), Abstract ASCO meeting 2012, C0-I

Latest Articles

The Fight Against Renal Cancer

The Fight Against Renal Cancer

In Hong Kong, there are 600 new cases of renal cancer every year. Although the incidence of renal cancer is not as high as cancers of the intestines or lungs, its prevalence has risen as high as 50% annually. If the cancer is diagnosed as Stage I, II or III, the most likely initial treatment [...]
Return to top of page